سعر كوادريديرم كريم 15جم 2025

Topical cream combining a corticosteroid (betamethasone), an aminoglycoside antibiotic (gentamicin), an antifungal (tolnaftate) and an antibacterial/antifungal (clioquinol); 15 g tube.

• Inflammatory corticosteroid-responsive dermatoses complicated by (or at risk of) secondary infection with susceptible organisms, including tinea pedis, cruris and corporis, intertrigo, eczematoid/contact/seborrhoeic dermatitis, impetigo and anal pruritusSchering-Plough S.A. (leaflet hosted by medicarcp.com)

• Local reactions with topical corticosteroids: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral and allergic contact dermatitis, skin maceration, secondary infection, atrophy, striae, miliaria; rash/irritation/hypersensitivity with gentamicin, clioquinol and rarely tolnaftate.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)

• History of sensitivity reactions to any of its components.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)

• Systemic corticosteroid effects including HPA-axis suppression may occur, especially in infants and children, with extensive areas, occlusion or long-term use; children may develop Cushing syndrome, growth retardation and intracranial hypertension.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)
• Systemic absorption of gentamicin may increase with extensive areas, prolonged use or damaged skin; prolonged use may cause overgrowth of non-susceptible organisms; not for ophthalmic use.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)
• Clioquinol may interfere with thyroid function tests, give a false-positive ferric chloride test for phenylketonuria and stain linen/clothing.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)

• Use in pregnancy only if benefit justifies the potential risk; avoid extensive amounts or prolonged use in pregnant patients.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)
• Unknown whether topical corticosteroids reach breast milk; decide whether to discontinue nursing or the drug.International label, equivalent formulation · Schering-Plough S.A. (leaflet hosted by medicarcp.com)